CN111088252B - A kind of specific labeling method of 5-hydroxymethyluracil on DNA - Google Patents
A kind of specific labeling method of 5-hydroxymethyluracil on DNA Download PDFInfo
- Publication number
- CN111088252B CN111088252B CN201911404293.9A CN201911404293A CN111088252B CN 111088252 B CN111088252 B CN 111088252B CN 201911404293 A CN201911404293 A CN 201911404293A CN 111088252 B CN111088252 B CN 111088252B
- Authority
- CN
- China
- Prior art keywords
- hmu
- dna
- labeling
- hydroxymethyluracil
- phosphorothioate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002372 labelling Methods 0.000 title claims abstract description 30
- JDBGXEHEIRGOBU-UHFFFAOYSA-N 5-hydroxymethyluracil Chemical compound OCC1=CNC(=O)NC1=O JDBGXEHEIRGOBU-UHFFFAOYSA-N 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 28
- 238000006243 chemical reaction Methods 0.000 claims abstract description 19
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims abstract description 16
- 125000003396 thiol group Chemical group [H]S* 0.000 claims abstract description 14
- 108091000080 Phosphotransferase Proteins 0.000 claims abstract description 10
- XBCXJKGHPABGSD-UHFFFAOYSA-N methyluracil Natural products CN1C=CC(=O)NC1=O XBCXJKGHPABGSD-UHFFFAOYSA-N 0.000 claims abstract description 10
- 102000020233 phosphotransferase Human genes 0.000 claims abstract description 10
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 claims abstract description 9
- 238000004132 cross linking Methods 0.000 claims abstract description 7
- 238000012546 transfer Methods 0.000 claims abstract description 5
- 108020004414 DNA Proteins 0.000 claims description 53
- 102000053602 DNA Human genes 0.000 claims description 18
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 claims description 9
- 108091008146 restriction endonucleases Proteins 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 5
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 4
- 108091034117 Oligonucleotide Proteins 0.000 claims description 4
- 238000006073 displacement reaction Methods 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 claims description 2
- IRPYIKUBZVGLRD-UHFFFAOYSA-N P(=S)#CC=1C(NC(NC1)=O)=O Chemical compound P(=S)#CC=1C(NC(NC1)=O)=O IRPYIKUBZVGLRD-UHFFFAOYSA-N 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000012070 reactive reagent Substances 0.000 claims description 2
- 108010077895 Sarcosine Proteins 0.000 claims 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract description 5
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229940035893 uracil Drugs 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 14
- 239000002777 nucleoside Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000754455 Pseudomonas virus M6 Species 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 125000003835 nucleoside group Chemical group 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 101710163270 Nuclease Proteins 0.000 description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000593 degrading effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 229940113082 thymine Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- RYVNIFSIEDRLSJ-UHFFFAOYSA-N 5-(hydroxymethyl)cytosine Chemical compound NC=1NC(=O)N=CC=1CO RYVNIFSIEDRLSJ-UHFFFAOYSA-N 0.000 description 2
- BLQMCTXZEMGOJM-UHFFFAOYSA-N 5-carboxycytosine Chemical compound NC=1NC(=O)N=CC=1C(O)=O BLQMCTXZEMGOJM-UHFFFAOYSA-N 0.000 description 2
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- -1 aldehyde group modified uracil Chemical class 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000009615 deamination Effects 0.000 description 2
- 238000006481 deamination reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000001973 epigenetic effect Effects 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 208000031448 Genomic Instability Diseases 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
- 229960004413 flucytosine Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 125000005179 haloacetyl group Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003774 sulfhydryl reagent Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 108010066651 thiophosphatase Proteins 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种DNA上5‑羟甲基尿嘧啶的特异性标记方法，属于分子生物学技术领域。该特异性标记方法利用从铜绿假单胞菌噬菌体M6中分离出的5‑hmU激酶实现γ‑硫代磷酸酯从5‑O‑硫代三磷酸腺苷转移到5‑hmU，产生5‑硫代磷酸甲基尿嘧啶；然后，通过液相色谱‑串联质谱法对产生的5‑硫代磷酸甲基尿嘧啶进行表征，并利用交联化学标记巯基对DNA上的5‑羟甲基尿嘧啶实现特异性标记。本发明的方法有效克服了检测样品需求量大、化学反应条件苛刻、反应效率低等缺点。
The invention discloses a specific labeling method of 5-hydroxymethyluracil on DNA, and belongs to the technical field of molecular biology. This specific labeling method utilizes 5-hmU kinase isolated from Pseudomonas aeruginosa phage M6 to transfer γ-phosphorothioate from 5-O-ATP to 5-hmU, producing methyl 5-phosphorothioate uracil; then, the resulting 5-phosphorothioate methyluracil was characterized by liquid chromatography-tandem mass spectrometry, and cross-linking chemically labeled sulfhydryls to achieve specificity for 5-hydroxymethyluracil on DNA mark. The method of the invention effectively overcomes the shortcomings of large demand for detection samples, harsh chemical reaction conditions, low reaction efficiency and the like.
Description
Technical Field
The invention belongs to the technical field of molecular biology, and relates to a specific labeling method of 5-hydroxymethyl uracil on DNA.
Background
The genome contains chemically modified DNA bases in addition to the four classical bases. These modified bases can be produced by endogenous enzymes or exogenous factors, which have the potential to profoundly affect genomic function and cellular processes. A number of modified DNA bases have been discovered, the most notable of which in the mammalian genome are 5-methylcytosine (5-methylcytosine, 5mC) and its oxidized derivative 5-hydroxymethylcytosine (5-hydroxymethythiocine, 5-hmC), 5-fluorocytosine (5-forcylcytosine, 5-fC) and 5-carboxycytosine (5-carboxycytosine, 5-caC). These epigenetic markers have been shown to play an important role in regulating gene expression. Methylation modification of DNA has been a focus of research in the field of epigenetics since its discovery in 1948. Methylation modification of DNA confers epigenetic memory to DNA duplexes in addition to protein coding information, with profound effects on genomic stability, gene expression and development. The result that researchers reported for the first time that TET enzyme can oxidize thymine to 5-hmU in 2014 reveals that oxidation products (5-hmU, 5-fU, 5-caU) of thymine (T) may have certain apparent significance.
5-hmU is a thymine derivative identified in the genome of various organisms. In mammals, 5-hmU is formed by post-replication processing mechanisms including thymine hydroxylation by a 10-11 translocase (TET) or Reactive Oxygen Species (ROS) and 5-hmC deamination. However, the level of modified bases in genomic DNA is affected by many factors, such as the type of cell or tissue and the disease state of the organism. most of 5-hmU in mES cells is produced by TET enzyme oxidase, while the deamination or ROS pathway of 5-hmC is rare. Thus, the matched 5-hmU: a but not mismatched 5-hmU: g is the predominant form of 5-hmU present in the mammalian genome. Studies have been carried out to date which show a composition of 5-hmU with few thymine residues, e.g.5-hmU in mES cells representing about 0.00005% and an abundance of only 0.1% of 5-hmC. This makes analysis of hmU difficult and the structural similarity between 5-hmU and 5-hmC prevents differentiation between these modifications. Therefore, there is a need for an efficient method for labeling 5-hmU on DNA for further identification and joint detection and exploration of its biological functions.
The current method for detecting 5-hmC in DNA samples is to convert 5-hmU to 5-fU by chemical oxidation to detect genome 5-hmU. By forming 5-fU: g base pairing, two induced T to C base changes. However, the efficiency of this induced change was low, the rate of this base change was less than 40% even under optimized conditions, and the functional tag label 5-hmU could not be used.
In addition, there are other detection methods 5-hmU. Research shows that the aldehyde group modified uracil (5fU) may play a certain role in epigenetics, such as base mismatch introduction, DNA structure change and the like. The traditional 5fU-DNA chain is synthesized mainly through Pt catalytic oxidation, osmium oxidation, sodium periodate oxidation and the like, and because catalysts used by the traditional 5fU-DNA chain are extremely toxic and are purchased limitedly, the requirement on equipment is high, so that no significant breakthrough exists in 5fU-DNA synthesis for a long time. To address this issue, researchers have designed and synthesized a biotinylated probe, coupled to Biotin, that can be applied at a later stage to the Biotin-Avidin System (BAS) to achieve selective enrichment for 5 fU. However, this method also has high reactivity to other aldehyde group-bearing components present in genomic DNA.
Therefore, there is a need for an efficient method for labeling 5-hmU on DNA for further identification and joint detection and exploration of biological functions.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention aims to provide a method for specifically labeling 5-hydroxymethyl uracil on DNA, which solves the problems of large sample requirement, harsh chemical reaction conditions, low reaction efficiency and the like in the prior art.
In order to achieve the purpose, the invention adopts the following technical scheme to realize the purpose:
the invention discloses a specific labeling method of 5-hydroxymethyl uracil on DNA, which utilizes 5-hmU kinase separated from pseudomonas aeruginosa bacteriophage M6 to realize the transfer of gamma-thiophosphate from 5-O-thiophosphoric acid adenosine triphosphate to 5-hmU and generate 5-thiophosphoric acid methyl uracil; then, the generated 5-thiophosphoric acid methyl uracil is characterized by a liquid chromatography-tandem mass spectrometry method, and the 5-hydroxymethyl uracil on the DNA is specifically marked by utilizing a cross-linking chemical labeling sulfhydryl.
5-hmU used in the present invention is a kinase isolated from Pseudomonas aeruginosa bacteriophage M6 and purchased directly.
Preferably, the specific procedure for producing 5-thiophosphoryl methyl uracil is as follows:
1) preparing a dsDNA oligonucleotide containing a recognition sequence for restriction endonuclease NcoI as a substrate for 5-hmU kinase;
2) preparing a dsDNA model substrate comprising different base pair sites by in vitro DNA polymerase catalyzed extension of the primers;
3) mixing a mixture containing 5-hmU: incubating the dsDNA product of A with the G template for a strand displacement reaction;
4) phosphorothioate ATP- γ -S with 5-hmU kinase 5-hmU: residues 5-hmU in A to give 5-thiophosphorylmethyl uracil.
Further preferably, in step 1), the recognition sequence for the restriction endonuclease NcoI is 5'-CCAXGG-3', wherein X ═ T, U, hmU and fU.
Further preferably, in step 2), the different base pairs comprise:
5 hmU: a, 5 hmC: g, 5 fC: g, 5 fU: a, U: a or T: A.
further preferably, the step 4) is specifically operated as follows:
10U 5-hmU kinase and 1mM ATP-. gamma. -S were added to the sample, and the reaction was performed in a 1 XCutsmart buffer reaction system at 37 ℃ for 2 hours with shaking at 300rpm, and then the microgel was washed 3 times with 1XPBS to obtain 5-thiophosphoric acid methyluracil.
Preferably, the specific operation of labeling thiol groups with crosslinking chemistry is as follows:
the specific recognition and labeling of the different 5-hmU sites to distinguish 5-hmU in the same genomic DNA sample or single cell was performed by thiol-reacting with phosphorothioate groups by adding different thiol-reactive reagents (iodosyl-alkynyl, haloacetyl, maleimide, etc.).
Further preferably, the thiol reaction is carried out at 37 ℃ for 1h in the absence of light.
Compared with the prior art, the invention has the following beneficial effects:
the invention utilizes 5-hmU DNA kinase (5-HMUDK) of pseudomonas aeruginosa bacteriophage M6 to realize the transfer of gamma-phosphorothioate from 5-O-adenosine triphosphate (ATP-gamma-S) to 5-hmU, and generate 5-thiophosphate methyl uracil (5 psmU). The resulting 5psmU was detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) technique followed by specific labeling of 5-hmU on DNA by cross-linking chemically labeled thiol groups. The concrete advantages are as follows:
1) the marking method can carry out selective 5-hmU identification and marking, namely, errors caused by chemical modification of other bases can be avoided, and accurate identification and marking can be realized.
2) The ATP-gamma-S of the present invention, which is a substrate and inhibitor of the ATP-dependent enzyme system, is hydrolyzed by phosphatases and most ATPases, but the hydrolysis process is slow. And once the thiophosphatase is phosphorylated, the protein becomes resistant to the protein phosphatase. ATP-gamma-S is a double bond oxygen on the most distant phosphate group in ATP, which is changed into S atom, and gamma-phosphorothioate can be transferred to a target under the action of 5-HMUDK, and then the target on genomic DNA can be identified and labeled, so that the accuracy and sensitivity of analysis are improved.
3) The 5-thiophosphoryl methyl uracil (5psmU) is generated by transferring gamma thiophosphoric acid to 5-hmU under the action of HMUDK by ATP-gamma-S. The specific labeling of 5-hmU on the DNA was then achieved by cross-linking chemically labeled thiol groups. The reaction is a chemical reaction with high yield, simple reaction conditions, high reaction speed and easily obtained raw materials and reaction reagents.
4) The LC-MS/MS can only separate volatile and non-decomposed substances by gas chromatography, the separation range of liquid chromatography is greatly widened, LC is combined with high-selectivity and high-sensitivity MS/MS, a complex sample can be analyzed in real time, and even under the condition that LC is difficult to separate, only neutral fragment scanning is carried out on a target compound by MS1 and MS2, the target compound in a mixture can be found and highlighted, and the signal-to-noise ratio is obviously improved.
Drawings
FIG. 1 is a schematic diagram of the present invention;
FIG. 2 is a melting curve of DNA;
FIG. 3 is a nucleoside chromatogram;
FIG. 4 is a mass spectrum of labeled 5-hmU.
Detailed Description
In order to make the technical solutions of the present invention better understood, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
It should be noted that the terms "first," "second," and the like in the description and claims of the present invention and in the drawings described above are used for distinguishing between similar elements and not necessarily for describing a particular sequential or chronological order. It is to be understood that the data so used is interchangeable under appropriate circumstances such that the embodiments of the invention described herein are capable of operation in sequences other than those illustrated or described herein. Furthermore, the terms "comprises," "comprising," and "having," and any variations thereof, are intended to cover a non-exclusive inclusion, such that a process, method, system, article, or apparatus that comprises a list of steps or elements is not necessarily limited to those steps or elements expressly listed, but may include other steps or elements not expressly listed or inherent to such process, method, article, or apparatus.
The invention is described in further detail below with reference to the accompanying drawings:
referring to FIG. 1, a schematic diagram of the method for specifically labeling DNA 5-hmU of the present invention, which achieves the transfer of gamma-phosphorothioate from ATP-gamma-S to 5-hmU using 5-HMUDK, yielding 5 psmU; specific labeling of 5-hmU was then achieved using a thiol-reactive iodoacyl-alkynyl reagent to react with the thiol group of the phosphorothioate group. Specifically, the method comprises the following steps:
1) preparing dsDNA oligonucleotides containing recognition sequences for the restriction endonuclease NcoI (5'-CCAXGG-3', X ═ T, U, hmU and fU) as substrates for 5-HMUDK;
2) extension of the primer by in vitro DNA polymerase catalysis, a primer containing a different base pair was prepared (5 hmU: a, 5 hmC: g, 5 fC: g, 5 fU: a, U: a or T: A) dsDNA model substrates for the sites;
3) to form a gel containing 5 hmU: g dsDNA, will contain 5-hmU: incubating the dsDNA product of A with a G template for a strand displacement reaction;
4) phosphorothioate ATP- γ -S5-hmU using the 5-hmU DNA kinase of pseudomonas aeruginosa bacteriophage M6: residues 5-hmU in A, making 5 psmU;
5) adding a sulfhydryl-reactive iodoacyl-alkynyl reagent to react with sulfhydryl of a phosphorothioate group, then degrading the dsDNA sample into nucleosides through nuclease and phosphatase, and detecting the nucleosides of each sample obtained through LC-MS/MS to complete the discrimination of different bases.
Example 1: the specific labeling method of 5-hmU is used for realizing the differentiation of different bases.
dsDNA oligonucleotide sequences containing different bases (containing restriction endonuclease NcoI sites 5'-CCAXGG-3', X ═ T, U, hmU and fU) were prepared, and dsDNA model substrates containing different base pair (5 hmU: a, 5 hmC: G, 5 fC: G, 5 fU: a, U: a or T: a) sites were prepared by in vitro DNA polymerase catalyzed extension of the primers.
Wherein, to form a composition comprising 5 hmU: g dsDNA, will contain 5-hmU: the dsDNA product of A was incubated with the G template for strand displacement reactions. The products were characterized in a model DNA labeling reaction by 5-HMUDK and SH reagents. As shown in FIG. 2, which is a melting curve of a DNA sample cleaved by restriction endonuclease NcoI, it can be seen that 5psmU of the reaction product can block the cleavage of DNA by NcoI.
5-HMUDK phosphorothioates ATP- γ -S5-hmU: specifically, 5-HMUDK phosphorothioates ATP- γ -S5-hmU: residues 5-hmU in A; adding 10U 5-HMUDK and 1mM ATP-gamma-S into a sample, carrying out a shaking reaction for 2 hours at 37 ℃ and 300rpm in a 1 XCutsmart buffer reaction system, and then washing the microgel with 1XPBS for 3 times to obtain 5 psmU; after a DNA sample is cut by restriction endonuclease NcoI, the sample is subjected to chromatographic detection, the result is shown in figure 3, and as can be seen from figure 3, different retention times of liquid phase mass spectrometry prove that the method has good specificity and selectivity on base pairs.
Then adding a thiol-reactive iodoacyl-alkynyl reagent to react with the thiol group of the phosphorothioate group, adding 100 mu M of the iodoacyl-alkynyl reagent to the sample, and further reacting for 1 hour at 37 ℃ in the dark to complete the thiol reaction on the phosphorothioate group.
Degrading the dsDNA sample into nucleosides by nuclease and phosphatase after the reaction is finished, and degrading all purified dsDNA samples into nucleosides by nuclease and phosphatase before analysis so as to ensure the accuracy of LC-MS/MS detection; and detecting the obtained nucleoside of each sample by LC-MS/MS, and analyzing the result to complete the discrimination of different bases. The results are shown in FIG. 4, and it can be seen from FIG. 4 that the mass spectrum and data after labeling demonstrate that the labeling method successfully achieves the specific labeling of 5-hmU sites on dsDNA samples.
The above-mentioned contents are only for illustrating the technical idea of the present invention, and the protection scope of the present invention is not limited thereby, and any modification made on the basis of the technical idea of the present invention falls within the protection scope of the claims of the present invention.
Claims (7)
1. A method for specifically labeling 5-hydroxymethyl uracil on DNA is characterized in that 5-hmU kinase is used for realizing the transfer of gamma-phosphorothioate from 5-O-thiophosphoric acid adenosine triphosphate to 5-hmU to generate 5-thiophosphoric acid methyl uracil; then, the generated 5-thiophosphoric acid methyl uracil is characterized by a liquid chromatography-tandem mass spectrometry method, and the 5-hydroxymethyl uracil on the DNA is specifically marked by utilizing a cross-linking chemical labeling sulfhydryl.
2. The method for labeling 5-hydroxymethyluracil on DNA according to claim 1, wherein the specific procedures for producing 5-phosphorothioate methylglycine are as follows:
1) preparing a dsDNA oligonucleotide containing a recognition sequence for restriction endonuclease NcoI as a substrate for 5-hmU kinase;
2) preparing a dsDNA model substrate comprising different base pair sites by in vitro DNA polymerase catalyzed extension of the primers;
3) mixing a mixture containing 5-hmU: incubating the dsDNA product of A with the G template for a strand displacement reaction;
4) phosphorothioate ATP- γ -S with 5-hmU kinase 5-hmU: residues 5-hmU in A to give 5-thiophosphorylmethyl uracil.
3. The method for labeling 5-hydroxymethyluracil on DNA as set forth in claim 2, wherein the recognition sequence for restriction endonuclease NcoI in step 1) is 5'-CCAXGG-3', wherein X is T, U, hmU and fU.
4. The method for labeling 5-hydroxymethyluracil on DNA according to claim 2, wherein the different base pairs in step 2) include:
5 hmU: a, 5 hmC: g, 5 fC: g, 5 fU: a, U: a or T: A.
5. the method for labeling 5-hydroxymethyluracil on DNA according to claim 2, wherein the step 4) is specifically performed as follows:
10U 5-hmU kinase and 1mM ATP-. gamma. -S were added to the sample, and the reaction was performed in a 1 XCutsmart buffer reaction system at 37 ℃ for 2 hours with shaking at 300rpm, and then the microgel was washed 3 times with 1xPBS to obtain 5-thiophosphoric acid methyluracil.
6. The method for labeling 5-hydroxymethyluracil on DNA according to claim 1, wherein the thiol group is labeled with a crosslinking chemistry by the following procedure:
the specific recognition and labeling of the different 5-hmU sites by thiol reaction with phosphorothioate groups by the addition of different thiol-reactive reagents to distinguish 5-hmU in the same genomic DNA sample or single cell.
7. The method for labeling 5-hydroxymethyluracil on DNA according to claim 6, wherein the thiol group is reacted at 37 ℃ for 1 hour under a dark condition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911404293.9A CN111088252B (en) | 2019-12-30 | 2019-12-30 | A kind of specific labeling method of 5-hydroxymethyluracil on DNA |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911404293.9A CN111088252B (en) | 2019-12-30 | 2019-12-30 | A kind of specific labeling method of 5-hydroxymethyluracil on DNA |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111088252A CN111088252A (en) | 2020-05-01 |
| CN111088252B true CN111088252B (en) | 2021-07-13 |
Family
ID=70396923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911404293.9A Active CN111088252B (en) | 2019-12-30 | 2019-12-30 | A kind of specific labeling method of 5-hydroxymethyluracil on DNA |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111088252B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112176043B (en) * | 2019-07-04 | 2022-07-12 | 北京大学 | Methods for sequencing, enrichment and detection of chemically labeled modified nucleosides |
| CN111850101B (en) * | 2020-06-29 | 2021-12-28 | 西安交通大学 | A Visual Discrimination Method for Spatial Localization and Proximity Distribution of Single-cell DNA Epigenetic Modifications |
| CN112708661B (en) * | 2021-01-27 | 2022-07-12 | 西安交通大学 | Visualization analysis method and system for intracellular 5-aldehyde uracil |
| CN114410762A (en) * | 2021-12-27 | 2022-04-29 | 武汉大学 | Phosphokinase-assisted localization analysis method and kit for 5-hydroxymethyluracil modification in DNA |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107573289A (en) * | 2017-09-13 | 2018-01-12 | 武汉大学 | A kind of compound of aldehyde radical uracil of specific chemical mark 5 and labeling method and application |
| CN109072225A (en) * | 2016-02-20 | 2018-12-21 | 弗拉迪米尔.I.巴什基洛夫 | Methods and systems for detecting target nucleic acids |
-
2019
- 2019-12-30 CN CN201911404293.9A patent/CN111088252B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109072225A (en) * | 2016-02-20 | 2018-12-21 | 弗拉迪米尔.I.巴什基洛夫 | Methods and systems for detecting target nucleic acids |
| CN107573289A (en) * | 2017-09-13 | 2018-01-12 | 武汉大学 | A kind of compound of aldehyde radical uracil of specific chemical mark 5 and labeling method and application |
Non-Patent Citations (2)
| Title |
|---|
| 《Cellular macromolecules-tethered DNA walking indexing to explore nanoenvironments of chromatin modifications》;Chen Feng等;《NATURE COMMUNICATIONS》;20210330;第12卷(第1期);第1-12页 * |
| 《Differentiated Visualization of Single-Cell 5-Hydroxymethylpyrimidines with Microfluidic Hydrogel Encoding》;Chen Feng等;《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》;20200127;第142卷(第6期);第2889-2896页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111088252A (en) | 2020-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111088252B (en) | A kind of specific labeling method of 5-hydroxymethyluracil on DNA | |
| RU2612902C2 (en) | Methods of detecting modification of nucleotides | |
| Xiong et al. | N1-methyladenosine methylome in messenger RNA and non-coding RNA | |
| Lv et al. | Advances in mapping the epigenetic modifications of 5‐methylcytosine (5mC), N6‐methyladenine (6mA), and N4‐methylcytosine (4mC) | |
| Korlach et al. | Going beyond five bases in DNA sequencing | |
| RU2698125C2 (en) | Libraries for next generation sequencing | |
| US20180327828A1 (en) | Ion sensor dna and rna sequencing by synthesis using nucleotide reversible terminators | |
| Nübel et al. | Boronate affinity electrophoresis for the purification and analysis of cofactor-modified RNAs | |
| Tomkuvienė et al. | Repurposing enzymatic transferase reactions for targeted labeling and analysis of DNA and RNA | |
| US20230076949A1 (en) | Targeted, long-read nucleic acid sequencing for the determination of cytosine modifications | |
| WO2000015844A1 (en) | Nucleic acid sequencing with solid phase capturable terminators | |
| US20170101675A1 (en) | Ion sensor dna and rna sequencing by synthesis using nucleotide reversible terminators | |
| Bai et al. | Simultaneous single-cell analysis of 5mC and 5hmC with SIMPLE-seq | |
| WO2013072515A1 (en) | Nucleic acid production and sequence analysis | |
| Cao et al. | Mapping messenger RNA methylations at single base resolution | |
| Tost | Current and emerging technologies for the analysis of the genome-wide and locus-specific DNA methylation patterns | |
| CN112840035A (en) | Methods of sequencing polynucleotides | |
| CN112326637A (en) | Chemiluminescence biosensor for detecting 5-hydroxymethylcytosine and detection method and application thereof | |
| Zhang et al. | Quantifying m6A and Ψ modifications in the transcriptome via chemical-assisted approaches | |
| Dou et al. | T7 RNA polymerase-mediated rolling circle transcription and the CRISPR-Cas13a cascade reaction for sensitive and specific detection of piRNA | |
| Kisil et al. | Methods for Detection and Mapping of Methylated and Hydroxymethylated Cytosine in DNA | |
| Li et al. | Chemical and Enzyme‐Mediated Chemical Reactions for Studying Nucleic Acids and Their Modifications | |
| Tserovski et al. | Diastereoselectivity of 5-Methyluridine Osmylation is inverted inside an RNA chain | |
| Wang et al. | Chemical labelling for M6a detection: opportunities and challenges | |
| Fei et al. | Unraveling the RNA Tapestry: A Symphony of Innovations in m6A Research Technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |